Ribomic Inc. reported earnings results for the nine months ended December 31, 2022. For the nine months, the company reported sales was JPY 3.33 million compared to JPY 7.5 million a year ago. Net loss was JPY 1,476.68 million compared to JPY 1,114.3 million a year ago.

Basic loss per share from continuing operations was JPY 49.87 compared to JPY 39.86 a year ago.